Table 2.
Baseline (Time 0) versus follow-up at 5 months (Time 1) comparison.
| N = 32 | Baseline (Time 0) | Time 1 | p-value |
|---|---|---|---|
| % LTCD3b | 69.7 (66.2–75.1) | 70.4 (66.1–72.5) | 0.5188 |
| %LTCD4a | 44.5 ± 8.3 | 45.2 ± 7.1 | 0.316 |
| % LT CD8a | 21.7 ± 7.2 | 21 ± 6.4 | 0.0555 |
| CD4 countb | 1142 (890.5–1337) | 1033.5 (903.5–1361) | 0.8811 |
| CD8 counta | 564.6 ± 328.6 | 558.6 ± 300.6 | 0.7967 |
| CD4/CD8 ratiob | 2.2 (1.7–2.6) | 2.3 (1.7–2.7) | 0.0628 |
| % LB CD19b | 16.3 (12.9–20.3) | 16.4 (12.7–19.5) | 0.6808 |
| % LB CD20b | 16.5 (13–20.2) | 16.2 (12.6–18.4) | 0.489 |
| CD19 countb | 415.5 (278.5–570) | 356 (283.5–544) | 0.8959 |
| CD20 countb | 407 (275–574.5) | 351 (276.5–543.5) | 0.9925 |
| C3a | 164.7 ± 39.1 | 152.8 ± 23.9 | 0.0952 |
| C4a | 28.4 ± 10.4 | 30.5 ± 8.1 | 0.0714 |
| Leptin | 45.7 ±9.14 | 23.5 ±12.6 | <0.001 |
| Adiponectina | 21.3 (17.8–34.1) | 33.5 (23.85–50.05) | < 0.0001 |
| Anticardiolipin IgG antibodies b | 7.4 (6.1–10.4) | 6.4 (5.1–9.4) | 0.0125 |
| Anticardiolipin IgM antibodies b | 0.95 (0.75–1.4) | 1.15 (0.8–1.5) | 0.1711 |
| Rheumatoid factora | 5.7 ± 1.7 | 5.1 ± 1.8 | 0.0283 |
a
Mean ± SD.
b
Median (IQR).